Jointown Pharmaceutical Group announcement: The company has formally submitted the application materials for the public offering of REITs for medical warehousing and logistics infrastructure to the China Securities Regulatory Commission and the Shanghai Stock Exchange on September 20, 2024. The assets included in this issuance are pharmaceutical logistics and warehousing assets in the Dongxihu District of Wuhan City, with a total floor area of approximately 0.172 million square meters. If the issuance is completed, it is expected to increase the company's net income by no more than 0.7 billion yuan. This issuance will help enhance the company's image and brand value, accelerate asset liquidity, expand financing channels, and improve the company's asset operation capabilities. However, this issuance still requires approval from the China Securities Regulatory Commission and the Shanghai Stock Exchange.
九州通：已向中国证监会和上海证券交易所正式提交医药仓储物流基础设施公募REITs申报材料
Jointown Pharmaceutical Group: It has formally submitted the application materials for the public offering of REITs for medical warehousing and logistics infrastructure to the China Securities Regulatory Commission and the Shanghai Stock Exchange.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.